Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preventing stroke.

× No keyword cloud information.

8 in total

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

Review 2. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?

Authors: T Stys; W E Lawson; G C Smaldone; A Stys
Journal: Arch Intern Med Date: 2000-05-22

3. Improved endothelial function with angiotensin-converting enzyme inhibitors.

Authors: C J Pepine
Journal: Am J Cardiol Date: 1997-03-06 Impact factor: 2.778

4. Use of ramipril in preventing stroke: double blind randomised trial.

Authors: Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeff Probstfield
Journal: BMJ Date: 2002-03-23

5. Modifying the natural history of atherosclerosis: the SECURE trial.

Authors: E Lonn
Journal: Int J Clin Pract Suppl Date: 2001-01

Review 6. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Authors: E M Lonn; S Yusuf; P Jha; T J Montague; K K Teo; C R Benedict; B Pitt
Journal: Circulation Date: 1994-10 Impact factor: 29.690

7. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors:
Journal: Lancet Date: 2001-09-29 Impact factor: 79.321

Review 8. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors: R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal: Lancet Date: 1990-04-07 Impact factor: 79.321

8 in total

5 in total

Preventing stroke.

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Review 2. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?

3. Improved endothelial function with angiotensin-converting enzyme inhibitors.

4. Use of ramipril in preventing stroke: double blind randomised trial.

5. Modifying the natural history of atherosclerosis: the SECURE trial.

Review 6. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

7. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Review 8. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

1. Preventing stroke with ramipril. Results should have been presented in ways that help practising clinicians.

2. Doctors' self rating of skills in evidence based medicine. Way that clinical epidemiology is taught must be examined.

3. Benefit of initial dual-therapy on stroke prevention in Chinese hypertensive patients: a real world cohort study.

Review 4. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.

Review 5. Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease.